Results 281 to 290 of about 6,591,243 (297)

Genome destabilization by homologous recombination in the germ line

Nature Reviews Molecular Cell Biology, 2010
Scott Keeney
exaly  

Criticism, Research, and Tag Lines

The Clearing House: A Journal of Educational Strategies, Issues and Ideas, 1959
openaire   +1 more source

Next-generation characterization of the Cancer Cell Line Encyclopedia

Nature, 2019
Mahmoud Mahdi Ghandi, Franklin W Huang, Gregory V Kryukov   +2 more
exaly  

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lancet, The, 2013
Dieter Hoelzer
exaly  

Zeros on the critical line

2014
openaire   +1 more source

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Lancet, The, 2014
Edward B Garon, Oscar Arrieta, Keunchil Park   +2 more
exaly  

Anal cancer: Current standards in care and recent changes in practice

Ca-A Cancer Journal for Clinicians, 2015
exaly  

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Lancet, The, 2012
Jeffrey A Cohen, Alasdair J Coles, Douglas L Arnold   +2 more
exaly  

Bottom Line, Mission-Critical Benefits

2015
openaire   +1 more source

Immune checkpoint inhibitors are superior to docetaxel as second‐line therapy for patients with non‐small cell lung carcinoma

Ca-A Cancer Journal for Clinicians, 2018
exaly